SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-3 - Registration statement by foreign private issuers:
SEC Accession No. 0001193125-20-094875
Filing Date
2020-04-02
Accepted
2020-04-01 18:42:38
Documents
6

Document Format Files

Seq Description Document Type Size
1 F-3 d897380df3.htm F-3 318617
2 EX-5.1 d897380dex51.htm EX-5.1 21013
3 EX-5.2 d897380dex52.htm EX-5.2 18896
4 EX-23.1 d897380dex231.htm EX-23.1 1508
5 GRAPHIC g897380g0401110652323.jpg GRAPHIC 4008
6 GRAPHIC g897380g99p62.jpg GRAPHIC 2587
  Complete submission text file 0001193125-20-094875.txt   370421
Mailing Address 190 ELGIN AVENUE GEORGE TOWN GRAND CAYMAN E9 KY1-9005
Business Address 190 ELGIN AVENUE GEORGE TOWN GRAND CAYMAN E9 KY1-9005 617-600-6888
Stealth BioTherapeutics Corp (Filer) CIK: 0001696396 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: F-3 | Act: 33 | File No.: 333-237542 | Film No.: 20766872
SIC: 2834 Pharmaceutical Preparations